LOGO
LOGO

Earnings News

Diebold Q1 Profit Rises; Lifts FY12 Outlook - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Diebold Inc. (DBD) reported that its first-quarter net income attributable to the company was $45.2 million, or $0.71 per share, up from $2.5 million, or $0.04 per share in the year ago quarter.

Non-GAAP income from continuing operations attributable to the company, net of tax, in the first quarter 2012 was $0.74 per share, compared with $0.23 per share from the first quarter 2011.

Revenue for the quarter was $698.49 million, up 13.7% from $614.16 million in the first quarter 2011.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.34 per share on revenues of $648.73 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead for fiscal 2012, the company now expects GAAP earnings to be in the range of $2.38 - $2.61 per share, compared to prior outlook of $2.18 - $2.41 per share.

The company raised its fiscal 2012 non-GAAP earnings outlook to a range of $2.50 - $2.70 per share, from the prior outlook of $2.30 - $2.50 per share.

The company now expects total revenue growth of 7% to 10%. Previously, the company expected total revenue growth of 3% to 6%.

Analysts expect the company to report earnings of $2.44 per share on revenues of $2.97 billion for fiscal 2012.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19